Brinson Patrick initiated coverage on shares of Rexahn Pharmaceuticals (NYSE:RNN) in a research note released on Monday morning, TheFlyOnTheWall.com reports. The firm issued an outperform rating on the stock. Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN) shares after opening at $1.22 moved to $1.23 on last trade day and at the end of the day closed at $1.13. Company price to sales ratio in past twelve months was calculated as – and price to cash ratio as 9.83. Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN) showed a negative weekly performance of -13.08%.
U.S. Geothermal (NYSE:HTM) was downgraded by Canaccord Genuity to a “sell” rating in a research note issued on Wednesday, AmericanBankingNews.com reports. The analysts noted that the move was a valuation call. U.S. Geothermal Inc. (NYSEMKT:HTM) shares fell -3.10% in last trading session and ended the day on $0.810. U.S. Geothermal Inc. (NYSEMKT:HTM) yearly performance is 145.45%.
North American Palladium Ltd (USA) (NYSEMKT:PAL) announced extension of cut off time and date for voting by proxy for the company’s upcoming shareholders’ meeting. North American Palladium Ltd (USA) (NYSEMKT:PAL) shares moved down -8.05% in last trading session and was closed at $0.481, while trading in range of $0.46 – $0.52. North American Palladium Ltd (USA) (NYSEMKT:PAL) year to date (YTD) performance is -26.15%.
Cowen and Company started coverage on shares of Idera Pharmaceuticals (NASDAQ:IDRA) in a research report released on Monday morning, TheFlyOnTheWall.com reports. The firm issued an outperform rating on the stock. Idera Pharmaceuticals Inc. (NASDAQ:IDRA) weekly performance is -36.42%. On last trading day company shares ended up $4.19. Idera Pharmaceuticals Inc. (NASDAQ:IDRA) distance from 50-day simple moving average (SMA50) is -18.35%. Analysts mean target price for the company is $7.00.